ACB - CONSENSUS CO - Aurora Cannabis

Aurora Cannabis (ACB) relies on creating a closed-loop medication production cycle, where proprietary strains and support for medical centers retain customers. This price chart reflects a consensus forecast of 3.84, while oversupply and market dumping undermine profitability. The Canadian business is currently shedding excess capacity in an effort to manage its debt burden following a period of aggressive acquisitions.

For Aurora Cannabis (ACB), the average market price target represents an aggregated forecast from professional analysts, reflecting the asset's expected capitalization while accounting for industry risks. This indicator measures the fundamental balance between the current price and fair value, helping to assess the effectiveness of the cost-reduction and debt-servicing strategy following a period of excessive mergers.